Haematologica (Jul 2020)
New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity
- Adnan Elhammali,
- Behrang Amini,
- Ethan B. Ludmir,
- Jillian R. Gunther,
- Sarah A. Milgrom,
- Chelsea C. Pinnix,
- Therese Andraos,
- Alison Yoder,
- Donna Weber,
- Robert Orlowski,
- Elisabet Manasanch,
- Krina Patel,
- Paolo Strati,
- Ranjit Nair,
- Hans C. Lee,
- Sheeba Thomas,
- Swaminathan Iyer,
- Gregory Kaufmann,
- Naveen Garg,
- Bouthaina S. Dabaja
Affiliations
- Adnan Elhammali
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
- Behrang Amini
- Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
- Ethan B. Ludmir
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
- Jillian R. Gunther
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
- Sarah A. Milgrom
- Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO
- Chelsea C. Pinnix
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
- Therese Andraos
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
- Alison Yoder
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
- Donna Weber
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Robert Orlowski
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Elisabet Manasanch
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Krina Patel
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Paolo Strati
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Ranjit Nair
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Hans C. Lee
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Sheeba Thomas
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Swaminathan Iyer
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Gregory Kaufmann
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Naveen Garg
- Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
- Bouthaina S. Dabaja
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
- DOI
- https://doi.org/10.3324/haematol.2019.235804
- Journal volume & issue
-
Vol. 105,
no. 7
Abstract
No abstracts available.
